John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$175M |
| 2 |
Kroger
KR
|
+$148M |
| 3 |
Elevance Health
ELV
|
+$122M |
| 4 |
EA
Electronic Arts
EA
|
+$120M |
| 5 |
Abbott
ABT
|
+$119M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$181M |
| 2 |
Halliburton
HAL
|
+$152M |
| 3 |
Pfizer
PFE
|
+$145M |
| 4 |
AGN
Allergan plc
AGN
|
+$124M |
| 5 |
AutoZone
AZO
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.33% |
| 2 | Technology | 13.07% |
| 3 | Consumer Discretionary | 10.5% |
| 4 | Financials | 9.32% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
CALL
Canadian Natural Resources
CNQ
$103B
| $709K | ﹤0.01% |
+46,966
| New | +$664K |
|
2002
PUT
The Mosaic Company
MOS
$7.74B
| $707K | ﹤0.01% |
+27,000
| New | +$716K |
|
2003
BlackRock TCP Capital
TCPC
$351M
| $707K | ﹤0.01% |
46,292
-8,165
| -15% | -$120K |
|
2004
NACCO Industries
NC
$321M
| $705K | ﹤0.01% |
55,085
-11,437
| -17% | -$147K |
|
2005
Navigator Holdings
NVGS
$1.32B
| $705K | ﹤0.01% |
61,310
+48,860
| +392% | +$687K |
|
|
KLXI
2006
DELISTED
KLX Inc.
KLXI
| $704K | ﹤0.01% |
26,916
-47,624
| -64% | -$1.31M |
|
|
BGFV
2007
DELISTED
Big 5 Sporting Goods
BGFV
| $700K | ﹤0.01% |
75,545
-3,514
| -4% | -$34.4K |
|
2008
CALL
3M
MMM
$92.3B
| $700K | ﹤0.01% |
4,784
-1,196
| -20% | -$169K |
|
|
FITB
2009
PUT
Fifth Third Bancorp
FITB
$50B
| $698K | ﹤0.01% |
39,700
-11,300
| -22% | -$203K |
|
2010
CALL
Regeneron Pharmaceuticals
REGN
$84.4B
| $698K | ﹤0.01% |
+2,000
| New | +$770K |
|
2011
Hanover Insurance
THG
$7.98B
| $697K | ﹤0.01% |
+8,232
| New | +$708K |
|
2012
Vanguard Morningstar Growth ETF
VUG
$226B
| $697K | ﹤0.01% |
+39,000
| New | +$694K |
|
2013
Koppers
KOP
$877M
| $696K | ﹤0.01% |
22,654
+3,654
| +19% | +$94.6K |
|
2014
Warner Bros
WBD
$72.2B
| $696K | ﹤0.01% |
+27,568
| New | +$753K |
|
|
GBNK
2015
DELISTED
Guaranty Bancorp
GBNK
| $695K | ﹤0.01% |
41,636
+30,664
| +279% | +$495K |
|
2016
Greif
GEF
$4.85B
| $692K | ﹤0.01% |
18,571
-194,661
| -91% | -$6.97M |
|
2017
Norwegian Cruise Line
NCLH
$7.88B
| $691K | ﹤0.01% |
+17,345
| New | +$827K |
|
2018
Bio-Rad Laboratories Class A
BIO
$10.4B
| $690K | ﹤0.01% |
4,824
-32,250
| -87% | -$4.6M |
|
|
VMRK
2019
CALL
Vivmark Residential
VMRK
$26.7B
| $689K | ﹤0.01% |
+10,000
| New | +$688K |
|
|
PLPM
2020
DELISTED
Planet Payment, Inc
PLPM
| $689K | ﹤0.01% |
+153,507
| New | +$626K |
|
2021
PUT
Vertex Pharmaceuticals
VRTX
$139B
| $688K | ﹤0.01% |
+8,000
| New | +$691K |
|
2022
CALL
CarMax
KMX
$9.08B
| $686K | ﹤0.01% |
+14,000
| New | +$719K |
|
2023
Lennar Class A
LEN
$21.1B
| $686K | ﹤0.01% |
+15,633
| New | +$684K |
|
2024
Titan Machinery
TITN
$438M
| $686K | ﹤0.01% |
61,519
-22,920
| -27% | -$263K |
|
2025
CALL
Welltower
WELL
$175B
| $686K | ﹤0.01% |
9,000
+6,000
| +200% | +$426K |
|
Similar funds
John Overdeck's Q2 2016 Portfolio in Review
As of Q2 2016, John Overdeck held 3,523 positions worth $23.3B, up 11% from $21B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $2B of net new capital in Q2 2016, opening 779 new positions and adding to 1,113 existing holdings. Its largest new stake was Kroger: 4,100,027 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $145M trimmed.
- John Overdeck's largest Q2 2016 buy was Kroger: 4,100,027 shares worth $151M.
- John Overdeck added most to Nike in Q2 2016, an estimated $175M increase.
- John Overdeck's biggest Q2 2016 reduction was Pfizer, cutting an estimated $145M.
- John Overdeck fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $181M.
- John Overdeck's ten largest holdings make up 7.4% of its $23.3B portfolio in Q2 2016.
- John Overdeck opened 779 new positions and closed 661 in Q2 2016.
- John Overdeck's portfolio value rose 11% quarter-over-quarter to $23.3B.
Based on Two Sigma Investments's 13F filing for Q2 2016, filed 15 Aug 2016.